May 5, 2015
ArcheMedX announced today, in collaboration with PIM and AcademicCME, the launch of an innovative continuing medical education (CME) program supported by an independent educational grant from Sanofi US and Regeneron Pharmaceuticals Alliance and powered by the ArcheViewer, a data-driven, e-learning software platform. This new educational program is designed to address advancements in monoclonal antibody therapeutics in dyslipidemia management and is being simultaneously distributed through five of the leading online CE portals including CME University, freeCME, myCME, Open CME, and POWER-PAK.
